title: Analytical issues in HPLC/MS/MS simultaneous assay of furosemide, spironolactone and canrenone in human plasma samples.
authors.affiliation: Bioanalytical Laboratory, S.C. LaborMed Pharma S.A., Th. Pallady Blvd. no. 44B, Bucharest 032266, Romania. iulia.sora@labormedpharma.ro
authors.forename: Daniela Iuliana
authors.initials: DI
authors.lastname: Sora
authors.forename: Stefan
authors.initials: S
authors.lastname: Udrescu
authors.forename: Florin
authors.initials: F
authors.lastname: Albu
authors.forename: Victor
authors.initials: V
authors.lastname: David
authors.forename: Andrei
authors.initials: A
authors.lastname: Medvedovici
mesh_terms: D002192:Canrenone / Q000097:blood*; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D005665:Furosemide / Q000097:blood*; D006801:Humans; D012015:Reference Standards; D015203:Reproducibility of Results; D021241:Spectrometry, Mass, Electrospray Ionization / Q000379:methods*; D013148:Spironolactone / Q000097:blood*; D053719:Tandem Mass Spectrometry / Q000379:methods*
chemical_list: D013148:Spironolactone; D002192:Canrenone; D005665:Furosemide